ROBERT PICCININI: Open Payments
NPI 1457443517 · STERLING HEIGHTS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,559 in 84 payments from 19 companies in 2025. Trend: 2023 $2,265 · 2024 $1,442 · 2025 $1,559
Food & beverage: $1,559
| Company | Payments | Amount |
|---|---|---|
| Validus Pharmaceuticals LLC | 14 | $227 |
| Vanda Pharmaceuticals Inc. | 12 | $208 |
| Lundbeck LLC | 9 | $169 |
| Alkermes, Inc. | 7 | $158 |
| Axsome Therapeutics, Inc. | 5 | $99 |
| Neurocrine BioSciences, Inc. | 4 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $77 |
| ABBVIE INC. | 4 | $70 |
| Supernus Pharmaceuticals, Inc. | 3 | $67 |
| Corium, LLC | 4 | $62 |
Products named: REXULTI, FANAPT, RALDESY, LYBALVI, Auvelity, INGREZZA, TRINTELLIX, VRAYLAR.
Industry payments across MI — which companies pay providers there.
